2022 China MedTech Industry Outlook
We recently released our annual China Medtech Outlook for this year, and highlighted three key trends for the industry. Industry players will need to better assess the trends and implications, proactively adapt to changes, and continue to innovate on multiple dimensions to survive and thrive.
Building on ongoing dialogues and in-depth discussions with leaders of the MedTech industry, our China Medtech Outlook is now out. In comparison to the results from last year, there are a few key themes emerging with important implications to the industry.
Increasing policy pressure
Volume-based procurement (VoBP), import substitution, and payment reform are the major policy thrusts in 2021, bringing price pressure and growth challenges to the industry.
Among them, VoBP has the largest near-term impact on the high-value consumables industry:
